View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
March 2, 2021

How UK’s Covid vaccine rollout can boost the economy post pandemic

By Paul Dennis

2 March

Faisal Islam, a political and economics journalist, shared an article on the vaccine rollout being the blueprint for UK’s recovery from the Covid-19 pandemic.

Economists opine that between fiscal tensions and extension of rescue packages, Rishi Sunak, Britain’s Chancellor was always going to point towards a changed economy in the upcoming budget.

However, the vaccine rollout, in particular, is being seen as timely to recover from the crisis.

It is also being expected that the chancellor will make the argument at the Budget that the Oxford-AstraZeneca coronavirus vaccine in the UK represents a model for medium-term changes in the economy.

The OxAz model will also see increased public participation, regulation, and significant state funding.

It is being speculated whether the government will spend equal sums of money at other forms of economic innovation, as it did for vaccines during the pandemic, by sourcing ventilators, protective equipment, and testing technologies.

Alok Sharma’s Department for Business, Energy and Industrial Strategy (BEIS) believes that the $16.2bn upfront expenditure on vaccines will bring potential benefits worth $15.2bn and $320bn, excluding wider health and social benefits.

Read more

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology